Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,956 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,331 · Balance 12,956 F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TENET HEALTHCARE CORP
Report date December 29, 2023 · Filed January 02, 2024
Section 16 reporting ended · disclosed 2024-01-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 488,129 |
Reported balance
After 2023-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-12-29 · Exercise / conversion · Acquired 33,586 · Balance 488,129 F1: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F2: Restricted stock units convert into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 474,912 |
Reported balance
After 2023-12-29 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-12-29 · Tax withholding · Disposed 13,217 · Balance 474,912 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. |
| 2023 March Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-12-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-12-29 · Exercise / conversion · Disposed 33,586 · Balance 0 F1: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F4: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend).
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F4: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2017 Filed May 2, 2017 23:40 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-029448 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on April 30, 2012, the reporting person received a grant of 25,000 time-based restricted stock units that vests in its entirety on the fifth anniversary of the date of grant. The fifth anniversary occurred on April 28, 2017 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 25,000 shares of common stock, as shown in Table I. F2 · security: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 21:50 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2016 March Restricted Stock Units · Derivative | 12,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020596 · doc4.xml · derivative · entry 3 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,053 Underlying: Common Stock · 12,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 24,053 restricted stock units are shown in Table II, of which 12,026 are scheduled to vest on March 10, 2018 and 12,027 are scheduled to vest on March 10, 2019. F1 · derivative.exercise_date: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 24,053 restricted stock units are shown in Table II, of which 12,026 are scheduled to vest on March 10, 2018 and 12,027 are scheduled to vest on March 10, 2019. F1 · derivative.expiration_date: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 24,053 restricted stock units are shown in Table II, of which 12,026 are scheduled to vest on March 10, 2018 and 12,027 are scheduled to vest on March 10, 2019. F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 21:50 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 5,094 | $19.22 | $97,906.68 |
DisclosureSEC source: 0001209191-17-020596 · doc4.xml · nonDerivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,344 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 21:50 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 12,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-020596 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 24,053 restricted stock units are shown in Table II, of which 12,026 are scheduled to vest on March 10, 2018 and 12,027 are scheduled to vest on March 10, 2019. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:49 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2017 March Performance Stock Options (Right to Buy) · Derivative | 89,976 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001209191-17-017880 · doc4.xml · derivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,976 Underlying: Common Stock · 89,976 shares Expires 2027-03-01 F2 · derivative.exercise_date: These performance-based stock options vest on the third anniversary of the date of grant, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $23.74 per share for any 20 consecutive trading days during the three-year period following the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:49 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2017 March Restricted Stock Units · Derivative | 40,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017880 · doc4.xml · derivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,373 Underlying: Common Stock · 40,373 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2014 February Performance-Based Restricted Stock Units · Derivative | 14,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · derivative · entry 12 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,284 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: As previously reported, on Feb. 26, 2014, the reporting person received a target grant of 21,425 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending Dec. 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 26, 2015, resulting in the vesting & settlement of 14,282 shares of common stock. The 2nd anniversary occurred on Feb. 26, 2016, resulting in the vesting & settlement of 14,284 shares of common stock. The 3rd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 14,284 shares of common stock, as shown in Table I. F6 · derivative.exercise_date: As previously reported, on Feb. 26, 2014, the reporting person received a target grant of 21,425 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending Dec. 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 26, 2015, resulting in the vesting & settlement of 14,282 shares of common stock. The 2nd anniversary occurred on Feb. 26, 2016, resulting in the vesting & settlement of 14,284 shares of common stock. The 3rd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 14,284 shares of common stock, as shown in Table I. F6 · derivative.expiration_date: As previously reported, on Feb. 26, 2014, the reporting person received a target grant of 21,425 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending Dec. 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 26, 2015, resulting in the vesting & settlement of 14,282 shares of common stock. The 2nd anniversary occurred on Feb. 26, 2016, resulting in the vesting & settlement of 14,284 shares of common stock. The 3rd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 14,284 shares of common stock, as shown in Table I. F7 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2014 February Restricted Stock Units · Derivative | 7,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · derivative · entry 11 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,142 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: As previously reported, on February 26, 2014, the reporting person received a grant of 21,425 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 7,141 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 7,142 shares of common stock. The third vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 7,142 shares of common stock, as shown in Table I. F5 · derivative.exercise_date: As previously reported, on February 26, 2014, the reporting person received a grant of 21,425 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 7,141 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 7,142 shares of common stock. The third vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 7,142 shares of common stock, as shown in Table I. F5 · derivative.expiration_date: As previously reported, on February 26, 2014, the reporting person received a grant of 21,425 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 7,141 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 7,142 shares of common stock. The third vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 7,142 shares of common stock, as shown in Table I. F7 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2015 February Performance-Based Restricted Stock Units · Derivative | 13,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · derivative · entry 10 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,235 Underlying: Common Stock · 13,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on Feb. 25, 2015, the reporting person received a target grant of 24,107 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 25, 2016, resulting in the vesting and settlement of 13,234 shares of common stock. The 2nd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 13,236 shares of common stock, as shown in Table I. The remaining 13,235 performance RSUs are shown in Table II, which are scheduled to vest on Feb. 25, 2018. F4 · derivative.exercise_date: As previously reported, on Feb. 25, 2015, the reporting person received a target grant of 24,107 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 25, 2016, resulting in the vesting and settlement of 13,234 shares of common stock. The 2nd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 13,236 shares of common stock, as shown in Table I. The remaining 13,235 performance RSUs are shown in Table II, which are scheduled to vest on Feb. 25, 2018. F4 · derivative.expiration_date: As previously reported, on Feb. 25, 2015, the reporting person received a target grant of 24,107 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 25, 2016, resulting in the vesting and settlement of 13,234 shares of common stock. The 2nd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 13,236 shares of common stock, as shown in Table I. The remaining 13,235 performance RSUs are shown in Table II, which are scheduled to vest on Feb. 25, 2018. F7 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2015 February Restricted Stock Units · Derivative | 8,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · derivative · entry 9 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,036 Underlying: Common Stock · 8,036 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 25, 2015, the reporting person received a grant of 24,107 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 8,035 shares of common stock. The second vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 8,036 shares of common stock, as shown in Table I. The remaining 8,036 restricted stock units are shown in Table II, which are scheduled to vest on February 25, 2018. F1 · derivative.exercise_date: As previously reported, on February 25, 2015, the reporting person received a grant of 24,107 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 8,035 shares of common stock. The second vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 8,036 shares of common stock, as shown in Table I. The remaining 8,036 restricted stock units are shown in Table II, which are scheduled to vest on February 25, 2018. F1 · derivative.expiration_date: As previously reported, on February 25, 2015, the reporting person received a grant of 24,107 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 8,035 shares of common stock. The second vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 8,036 shares of common stock, as shown in Table I. The remaining 8,036 restricted stock units are shown in Table II, which are scheduled to vest on February 25, 2018. F7 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 6,050 | $21.99 | $133,039.50 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 8 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,412 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 14,284 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 7 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: As previously reported, on Feb. 26, 2014, the reporting person received a target grant of 21,425 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending Dec. 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 26, 2015, resulting in the vesting & settlement of 14,282 shares of common stock. The 2nd anniversary occurred on Feb. 26, 2016, resulting in the vesting & settlement of 14,284 shares of common stock. The 3rd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 14,284 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 3,075 | $21.99 | $67,619.25 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 6 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,178 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 7,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 5 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: As previously reported, on February 26, 2014, the reporting person received a grant of 21,425 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 7,141 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 7,142 shares of common stock. The third vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 7,142 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 5,606 | $21.99 | $123,275.94 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 4 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,111 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 13,236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 3 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on Feb. 25, 2015, the reporting person received a target grant of 24,107 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these RSUs vest in one-third increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st anniversary occurred on Feb. 25, 2016, resulting in the vesting and settlement of 13,234 shares of common stock. The 2nd vesting date occurred on Feb. 24, 2017 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 13,236 shares of common stock, as shown in Table I. The remaining 13,235 performance RSUs are shown in Table II, which are scheduled to vest on Feb. 25, 2018. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 3,404 | $21.99 | $74,853.96 |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,481 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 00:36 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 8,036 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015524 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 25, 2015, the reporting person received a grant of 24,107 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 8,035 shares of common stock. The second vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 8,036 shares of common stock, as shown in Table I. The remaining 8,036 restricted stock units are shown in Table II, which are scheduled to vest on February 25, 2018. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.